Effects of in-feed clinoptilolite treatment on serum metabolic and antioxidative biomarkers and acute phase response in dairy cows during pregnancy and early …

…, N Maćešić, J Grizelj, T Dobranić, G Redžepi… - Research in veterinary …, 2019 - Elsevier
The objective of this study was to evaluate the effects of in-feed clinoptilolite (CPL) on serum
metabolic and antioxidative biomarkers, acute phase proteins and reproductive …

Chronic wounds as a public health problem

M ŠITUM, M Kolić, G REDŽEPI, S Antolić - Acta medica Croatica …, 2014 - hrcak.srce.hr
Chronic wounds represent a significant burden to patients; health care professionals and
the entire health care system. Regarding the healing process; wounds can be classified as …

[HTML][HTML] Successful treatment of autoimmune pulmonary alveolar proteinosis in a pediatric patient

M Turkalj, M Perica, Ž Ferenčić, D Erceg… - The American journal …, 2016 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Pulmonary alveolar proteinosis (PAP) is a rare condition
characterized by the intra-alveolar accumulation of surfactant-derived material, which …

Kronične rane kao javnozdravstveni problem.

M ŠITUM, M KOLIĆ, G REDŽEPI… - Acta Medica …, 2014 - search.ebscohost.com
Kronične rane su ogroman teret bolesnicima, medicinskom osoblju ali i cjelokupnom
zdravstvenom sustavu. Kronične rane su rane koje ne zarastaju unutar predviđenog razdoblja u …

[PDF][PDF] Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis

M Samardžija, D Srdić, G Redžepi, S Pleština… - Collegium …, 2008 - hrcak.srce.hr
… Miroslav Samar`ija1, Dra`ena Srdi}1, Gzim Red`epi1, Sanja Ple{tina1, Ivica Ma`urani}2,
Marko Jakopovi}1 and Neven Miculini}1 …

Adaptation and validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for Croatia

…, M Jakopović, A Vukić Dugac, G Redžepi… - Acta Clinica …, 2019 - hrcak.srce.hr
Pulmonary hypertension (PH) is a chronic disease which severely impairs quality of life (QoL).
The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first …

Overview and management of different post-COVID conditions

…, Ž Petelin Gadže, D Radić Krišto, G Redžepi… - … akademije znanosti i …, 2022 - hrcak.srce.hr
Coronavirus disease 2019 (COVID-19) pandemic resulted in global healthcare crises and
strained health resources, both in the acute and chronic phase of the disease. Similarly to post…

Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer

…, D Baričević, M Jakopović, G Redžepi - Collegium …, 2005 - hrcak.srce.hr
Aim of this study was to estimate efficacy of gemcitabine in first and the second-line
chemotherapy for patients with advanced non-small cell lung cancer (stage III and IV). In first-line …

Efficacy and Safety of Budesonide/Formeterol Combination Therapy in Asthma Patients

M Jakopović, F Pavičić, G Redžepi, S Pleština… - Collegium …, 2009 - hrcak.srce.hr
Budesonide/formoterol as single inhaler was developed for treating asthma patients who are
not adequately controlled on glucocorticoides alone. The aim of this study was to evaluate …

Safety and efficacy of erlotinib in patients with squamous cell lung cancer

…, M Korsic, Z Vrbica, G Redzepi… - European …, 2014 - Eur Respiratory Soc
Background:Erlotinib is epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor
which showed efficacy and tolerability in patients with advanced non-small cell lung cancer(…